Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6610 stock hub

TPEX/6610 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6610is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6610

In the news

Latest news · TPEX/6610

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-60.6

P25 -16.2P50 0.3P75 9.8

ROIC-36.8

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6610 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

TWD

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	23
Employees Change	2%
Employees Change Percent	9.52
Enterprise value	TWD 2.7B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006610009
Last refreshed	2026-05-10
Market cap	TWD 3B
Price	TWD 28.3
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/6610
Website	https://www.twibiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.13%
EV Earnings	-17.4x
EV/FCF	-20.61x
FCF yield	-4.33%
P/B ratio	11.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	TWD -155.3M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Profit Per Employee	TWD -6.8M
ROA	-27.83
Roa5y	-21.4
ROCE	-56.5
ROE	-60.59
Roe5y	-38.49
ROIC	-36.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	155.12%
Cagr3y	12.67%
Cagr5y	10.36%
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	TWD 393.6M
Cash	TWD 332.6M
Current Assets	TWD 334.7M
Current Liabilities	TWD 120.4M
Debt	TWD 4.3M
Debt Equity	TWD 0.02
Debt FCF	TWD -0.03
Equity	TWD 268.9M
Interest Coverage	-1,196.7
Liabilities	TWD 124.7M
Long Term Assets	TWD 58.9M
Long Term Liabilities	TWD 4.4M
Net Cash	TWD 328.3M
Net Cash By Market Cap	TWD 10.84
Net Cash Growth	46.87%
Net Debt Equity	TWD -1.22
Tangible Book Value	TWD 238.6M
Tangible Book Value Per Share	TWD 2.22
WACC	10.26

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.78
Net Working Capital	TWD -115.5M
Quick ratio	2.77
Working Capital	TWD 214.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	154.96%
200-day SMA	23.12
3Y total return	43.06%
50-day SMA	22.22
50-day SMA vs 200-day SMA	50under200
5Y total return	63.72%
All Time High	94
All Time High Change	-69.89%
All Time High Date	2016-12-27
All Time Low	5.19
All Time Low Change	445.28%
All Time Low Date	2020-03-19
ATR	2.32
Beta	1.09
Beta1y	0.87
Beta2y	0.6
Ch YTD	68.45
High	29.75
High52	40.85
High52 Date	2025-09-30
High52ch	-30.72%
Low	28.05
Low52	10.5
Low52 Date	2025-06-02
Low52ch	169.52%
Ma50ch	27.34%
Price vs 200-day SMA	22.42%
RSI	61.62
RSI Monthly	57.97
RSI Weekly	61.97
Sharpe ratio	1.52x
Sortino ratio	2.28
Total Return	-5.63%
Tr YTD	68.45
Tr1m	41.86%
Tr1w	-9.44%
Tr3m	31.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -154.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-2,627,000
Shares Insiders	0.25%
Shares Institutions	5.29%
Shares Out	107,629,000
Shares Qo Q	0.76%
Shares Yo Y	5.63%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -131.1M
Average Volume	828,087.85x
Bv Per Share	2.5
CAPEX	TWD -146,000
Ch1m	41.86
Ch1w	-9.44
Ch1y	155
Ch3m	31.02
Ch3y	37.38
Ch5y	57.22
Ch6m	-21.39
Change	-1.39%
Change From Open	-2.41
Close	28.7
Days Gap	1.05
Depreciation Amortization	7,097,000
Dollar Volume	13,852,680.2
Earnings Date	2026-04-02
EBIT	TWD -154.4M
EBITDA	TWD -147.3M
EPS	TWD -1.77
F Score	1
FCF	TWD -131.1M
FCF EV Yield	-4.85x
FCF Per Share	TWD -1.22
Financing CF	233,241,000
Fiscal Year End	December
Founded	2,010
Investing CF	31,950,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-06-30
Ma150	23.9
Ma150ch	18.42%
Ma20	25.21
Ma20ch	12.28%
Net CF	134,269,000
Open	29
Position In Range	14.71
Ppne	4,888,000
Price Date	2026-05-08
Ptbv Ratio	12.7
Relative Volume	0.6x
Share Based Comp	-1,000
Tr6m	-21.39%
Volume	489,494

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6610 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6610 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6610?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.3%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5.6%

Negative means the company is buying back shares.

Technical

TPEX/6610 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.6

Neutral momentum band

Price vs 200-day MA

+22.4%

50/200-day relationship not available

Beta (5Y)

1.09

Moves roughly with the market

Sharpe ratio

1.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6610

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6610 stock rating?

tpex/6610 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6610 analysis?

The full report lives at /stocks/tpex/6610/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6610?

The latest report frames tpex/6610 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6610 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.